Note trofinetide also requires cold chain distribution, whereas NNZ-2591 I believe does not. This in itself will mean lower manufacturing and distribution costs. It also implies to me that trofinetide is more fragile/unstable, which may mean more difficulty in manufacturing.Trofinetide also needs any unused portion to be discarded 14 days after opening (tho that might actually boost sales!)Nnz 2591 is a smaller molecule (194 vs 315 for Trofinetide) which, all else being equal, may also mean easier manufacture.
Probably the most important factor though is the NNZ-2591 dose is 10-20x lower. So with the same amount you could treat 10-20x number of patients.
All this implies the cost of the NNZ-2591 drug is likely significantly cheaper overall than Daybue.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.17%
!
$17.55

Share Price, page-15017
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.55 |
Change
0.540(3.17%) |
Mkt cap ! $2.211B |
Open | High | Low | Value | Volume |
$17.48 | $18.44 | $17.40 | $16.43M | 922.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2624 | $17.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.70 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2624 | 17.530 |
3 | 4257 | 17.500 |
1 | 1500 | 17.410 |
1 | 57 | 17.380 |
3 | 12000 | 17.350 |
Price($) | Vol. | No. |
---|---|---|
17.700 | 1000 | 1 |
17.750 | 50 | 1 |
17.780 | 200 | 1 |
17.810 | 50 | 1 |
17.910 | 2000 | 1 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |